There's a strange hierarchy in skincare actives. Retinoids get the glamour. Vitamin C gets the marketing budgets. Niacinamide gets the social media hype. And azelaic acid — arguably the most versatile single molecule in the entire dermatological toolkit — gets overlooked. Dermatica, a UK teledermatology company that spent its first three years writing prescriptions for custom compound treatments, decided to make their over-the-counter debut with the active most people don't know they need, at the concentration most brands are too cautious to offer.
Twenty percent azelaic acid is not a gentle introduction. This is the concentration used in prescription products — the same level that clinical trials have shown to be comparable in acne efficacy to tretinoin 0.05% and benzoyl peroxide 5%, while simultaneously demonstrating results against hyperpigmentation rivaling hydroquinone 4%. That a product this potent is available without a prescription feels almost like a regulatory oversight that consumers should quietly benefit from.
The formulation itself is where Dermatica's clinical background genuinely shows. Most high-concentration azelaic acid products — including the prescription standards — come in basic, functional vehicles that do little beyond delivering the active. Dermatica wrapped their 20% azelaic acid in a ceramide complex (NP, AP, and EOP), added phytosphingosine and cholesterol to complete the lipid barrier support system, and included squalane for comfortable emolliency. The result is a treatment product that actively protects the skin while treating it — the ceramides buffer the irritation potential of the high-concentration acid without diminishing its efficacy.
The texture reflects this dual ambition. It's lightweight and smooth, absorbing within seconds to a slightly matte finish that layers well under moisturizer and sunscreen. There's no grittiness from undissolved azelaic acid crystals, no heavy residue, no fragrance trying to mask a clinical smell. It feels like a well-made moisturizer that happens to contain a serious active ingredient. This matters more than it might seem — treatment compliance drops dramatically when a product is unpleasant to use, and Dermatica clearly engineered this for twice-daily comfort.
The first week or two will test your resolve. Twenty percent azelaic acid produces a mild tingling or warming sensation that typically lasts five to ten minutes after application. Some people describe it as a gentle prickling; others barely notice it. This is a known pharmacological effect of azelaic acid, not a sign of irritation, and it diminishes consistently as the skin acclimatizes. If you've ever used a high-percentage vitamin C serum, the sensation is comparable — noticeable but not alarming.
Once past the adjustment period, the product's versatility becomes apparent. Acne responds first — within two to four weeks, inflammatory lesions calm and new breakouts decrease in frequency and severity. Azelaic acid works differently from most acne treatments: it's antibacterial against Propionibacterium acnes, it normalizes keratinization to prevent pore blockage, and its anti-inflammatory action reduces the redness and swelling that make breakouts so visible. For hormonal acne along the jawline and chin, users consistently report meaningful improvement.
Hyperpigmentation improvements arrive more gradually, typically becoming visible at six to eight weeks. Azelaic acid inhibits tyrosinase — the enzyme responsible for melanin production — which makes it effective against post-inflammatory hyperpigmentation, melasma, and general dark spots. Unlike hydroquinone, it can be used long-term without the risk of ochronosis, and unlike many brightening agents, it's pregnancy-safe, making it one of the few evidence-based options for pregnant individuals dealing with melasma.
For rosacea, systematic reviews position azelaic acid as more effective than metronidazole 0.75% for reducing erythema and inflammatory lesions. This specific formulation's anti-inflammatory base — with ceramides and squalane rather than potentially irritating additives — makes it particularly suitable for rosacea-prone skin that reacts poorly to many treatment vehicles.
The honest limitation is size. At 30 milliliters, you're getting roughly six to eight weeks of product if used once daily on the full face. Twice-daily application cuts that in half. For a product designed for long-term consistent use, the ongoing cost accumulates — though it remains significantly cheaper than prescription azelaic acid formulations or dermatology consultations.
Dermatica is an emerging brand, and this warrants acknowledgment. Founded in 2018, they lack the decades of track record that established dermatological brands carry. However, their formulations are developed by a clinical team of consultant dermatologists and pharmacists, and the active ingredient itself has over thirty years of published clinical evidence. You're not betting on an untested ingredient — you're betting on a young brand's ability to formulate around a well-proven one. Based on this product, that bet looks increasingly solid.
At approximately twenty-five dollars for 30 milliliters, the value depends on what you're comparing it to. Against prescription azelaic acid products that cost more and come in less sophisticated vehicles, this is a bargain. Against lower-concentration OTC azelaic acid products, you're paying a premium for double or triple the active concentration and a demonstrably superior base. For the multi-condition effectiveness it provides — acne, rosacea, hyperpigmentation, and melasma in a single tube — the cost-per-condition treated is genuinely compelling.
The Dermatica Azelaic Acid 20% Cream is the kind of product that makes you wonder why more brands don't do this. Take a brilliantly effective, well-studied active. Use it at the concentration the evidence actually supports. Put it in a base that respects the skin it's treating. Sell it without a prescription. It's straightforward, evidence-driven skincare from a brand that literally started by writing prescriptions — and now they're making the prescription unnecessary.
